| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447063 | European Journal of Cancer | 2011 | 9 Pages |
Abstract
Hepatectomy is rarely performed for BCLM but the studies described in this review indicate consistent results with superior 5-year survival for selected patients with isolated liver metastases and in those with well controlled minimal extrahepatic disease. To evaluate its efficacy and control for selection bias, a randomised trial of standard chemotherapy with or without hepatectomy for BCLM is warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Terence C. Chua, Akshat Saxena, Winston Liauw, Francis Chu, David L. Morris,